Enlivex Ltd. (ENLV)
Enlivex develops Allocetra, a therapy for knee osteoarthritis, and holds RAIN tokens in its treasury. It last closed at $1.17 on Nov 17, up 6.36% on the day. ENLV last reported earnings on Fri, Sep 18, 2026.
Key Stats
Last 12 monthsNot reported for this period.
From ENLV's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Mar 25). Last 12 months adds up the four latest quarters. Per share figures are left out because the US listing can represent a different number of shares.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 3 | HC Wainwright & Co. | Maintained | Buy | $80 |
Technical Analysis
The stock is 57% below its 20 day and 391% below its 50 day average. It is 10525% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 16), oversold. The nearest support is the Pivot at $1.15, and the nearest resistance the Pivot R1 at $1.20.
| RSI (14) | 15.69 | Oversold below 30 | Oversold |
| MACD | -1.58 | Above its signal line | Bullish |
| Stochastic | 5.5 | Near the bottom of its range | Oversold |
| ADX (14) | 68.3 | Strong downtrend | |
| Williams %R | -90.3 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -69.6 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | −19.9% | Change over 10 sessions | Bearish |
| ATR (14) | $0.47 | Typical daily range, 39.9% of price |
| RSI (14) | 17.51 | Oversold below 30 | Oversold |
| MACD | -40.52 | Above its signal line | Bullish |
| Stochastic | 0.3 | Near the bottom of its range | Oversold |
| ADX (14) | 36.9 | Trending down | |
| Williams %R | -99.4 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -72.2 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | −92.4% | Change over 10 sessions | Bearish |
| ATR (14) | $13.09 | Typical daily range, 1118.5% of price |
What happened before
See how ENLV did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How ENLV has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2014.
Whale Options Flow
90DNo whale options trades in ENLV in the last 90 days.
ENLV Institutional Ownership
Full report →- ▼17 buying vs 24 selling
- ▼Shares held by funds -91.1%
- ▼Funds holding -8
- ●Superinvestors: 1 added, 1 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 17 | 25 | −32.0% |
| In funds' top 10 | 0 | 0 | – |
| Held by funds | – | – | – |
| New / increased | 17 / 0 | 5 / 9 | +21.4% |
| Reduced / sold out | 0 / 24 | 7 / 13 | +20.0% |
| Put/call ratio | – | – | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ENLV is in one of them and how their past ENLV trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered ENLV in an article yet. Here's the latest on the wider market.
About Enlivex
Enlivex is a drug development company based in Tel Aviv. It is developing Allocetra, a therapy designed to rebalance the immune system, and is testing it as a possible treatment for knee osteoarthritis, a joint condition linked to aging. The company also holds a treasury of RAIN, the governance token of a decentralized prediction markets platform built on the Arbitrum network.
- Headquarters
- Tel Aviv

